CHU Brugmann and Bulbitech join forces in diagnosing neuro-ophthalmological and neuro-vestibular disorders

Written By Gasta Design

At CHU Brugmann in Brussels, Belgium, Drs Alionka Bostan and Zachary Duvigneaud represent the neurologic clinic of vision and equilibrium, dedicated to the diagnosis of neuro-ophthalmological and neuro-vestibular disorders.

The integration of the Bulbitech device will play an important role in their clinical practice, enhancing the diagnosis and follow-up of neurodegenerative diseases and various neuro-ophthalmological and neuro-vestibular syndromes.

The team foresees also a potential for research applications, as this type of technology can be a powerful tool to deepen the understanding of eye movement disorders as early biomarkers of neurological diseases.

Dr. Duvigneaud and Dr. Bostan are excited to integrate this innovative technology into their clinical workflow at CHU Brugmann, and to contribute to the growing trend towards digital neuro-ophthalmology.

Gasta Design

Vi skaper lønnsame nettsider basert på Squarespace, og utviklar gjerne din visuelle identitet eller hjelper deg med digital markedsføring.

https://www.gasta.no/
Previous

Alexander Sverstad, MD reveals in lecture that Eye Movement Perimetry is capable of distinghuishing healthy individuals from those with mild to moderate glaucoma as effectively as SAP
Next

Rotschild Foundation Hospital and Bulbitech to collaborate on early biomarkers for AMD in NOGA1 study